Global Balloon-expandable Stents Market Size By Type (Bare-metal Stents, Drug-eluting Stents), By Application (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Balloon-expandable Stents Market was valued at USD 4.1 billion in 2023 and is projected to surpass USD 6.9 billion by 2031, growing at a CAGR of 6.6% during the forecast period of 2023–2031. The growth of the market is primarily driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and the continued advancement in stent technologies. Balloon-expandable stents offer superior radial strength and precision during deployment, making them highly suitable for coronary artery disease treatment and other vascular interventions.

Drivers:

Rising Incidence of Cardiovascular Disorders:

With heart diseases being a leading cause of death globally, there is an increasing demand for reliable and effective vascular interventions. Balloon-expandable stents are widely used in treating atherosclerotic lesions, offering a safe and effective solution.

Growing Preference for Minimally Invasive Procedures:

Minimally invasive treatments reduce recovery time, hospital stays, and post-operative complications. Balloon-expandable stents are deployed using catheter-based techniques, aligning perfectly with the global trend toward less invasive treatment methods.

Technological Advancements in Stent Design:

The market is witnessing continual improvements in stent materials and coatings. Developments such as drug-eluting and bioresorbable stents are boosting performance and patient outcomes, thereby expanding the market potential.

Restraints:

Risk of In-Stent Restenosis:

Despite advancements, restenosis remains a clinical concern, especially in complex lesions. This limitation can hinder adoption in certain patient groups.

High Cost of Advanced Stents:

Cutting-edge balloon-expandable stents come with significant cost implications, which can limit access in developing regions and among economically challenged populations.

Opportunity:

Emerging Markets in Asia-Pacific and Latin America:

Rapid urbanization, rising healthcare infrastructure investments, and increased awareness about cardiovascular health in emerging economies provide substantial market expansion opportunities.

Development of Next-Gen Biocompatible Materials:

Innovations in biodegradable polymers and hybrid materials offer manufacturers an opportunity to differentiate products and cater to patient safety and regulatory demands.

Market by System Type Insights:

Based on system type, the Drug-Eluting Stents (DES) segment held the largest market share in 2023. These stents are coated with medication that prevents restenosis, making them the preferred choice among interventional cardiologists. However, the Bare-Metal Stents (BMS) segment continues to find relevance in specific clinical scenarios such as large vessel diameters or in patients at high bleeding risk where long-term dual antiplatelet therapy is a concern.

Market by End-use Insights:

In terms of end-use, Hospitals emerged as the largest revenue contributor in 2023, accounting for over 60% of the market share. The availability of advanced interventional facilities and skilled cardiologists makes hospitals the primary point for stent implantations. Meanwhile, Ambulatory Surgical Centers (ASCs) are expected to witness the fastest growth due to reduced procedure costs and shorter recovery times.

Market by Regional Insights:

Geographically, North America dominated the balloon-expandable stents market in 2023, owing to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of cutting-edge medical technologies. Asia-Pacific is anticipated to register the highest CAGR during the forecast period due to increasing healthcare expenditures, improving awareness, and an aging population.

Competitive Scenario:

Key players operating in the global balloon-expandable stents market include:

Abbott Laboratories

Boston Scientific Corporation

Medtronic plc

BIOTRONIK SE & Co. KG

Terumo Corporation

Cook Medical

MicroPort Scientific Corporation

B. Braun Melsungen AG

Biosensors International Group

Cardinal Health

These companies are investing in R&D, pursuing regulatory approvals, and engaging in strategic partnerships to launch next-gen stents that combine efficacy with safety.

Scope of Work – Global Balloon-expandable Stents Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 6.9 billion

CAGR (2023–2031) 6.6%

Market Segments By System Type (DES, BMS), By End-use (Hospitals, ASCs, Cardiac Centers)

Growth Drivers Cardiovascular disease prevalence, minimally invasive procedures, technological advancements

Opportunities Emerging markets, biodegradable and bioresorbable stents

Key Market Developments:

2023: Abbott Laboratories received FDA approval for a next-gen bioresorbable drug-eluting balloon-expandable stent designed for high-risk patients with diabetes.

2024: Boston Scientific announced strategic acquisition of a catheter startup to enhance its interventional cardiology portfolio.

2025: Medtronic launched its hybrid balloon-expandable stent in select Asian markets, combining drug elution with novel anti-restenosis coating.

FAQs:

What is the current market size of the Global Balloon-expandable Stents Market?

The market was valued at USD 4.1 billion in 2023.

What is the major growth driver of the Global Balloon-expandable Stents Market?

The major growth driver is the increasing prevalence of cardiovascular diseases and the shift toward minimally invasive procedures.

Which is the largest region during the forecast period in the Global Balloon-expandable Stents Market?

North America remains the largest region due to advanced healthcare infrastructure and high procedure volumes.

Which segment accounted for the largest market share in Global Balloon-expandable Stents Market?

The Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023.

Who are the key market players in the Global Balloon-expandable Stents Market?

Key players include Abbott Laboratories, Boston Scientific, Medtronic, BIOTRONIK, and Terumo Corporation.